Colon Neoadjuvant FOLFOXIRI Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant SBRT With Concomitant Capecitabine in Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS
- Status
- RECRUITING
- Phase
- PHASE3
Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine With Digoxin for Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial for Large ER-Negative Breast Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine
- Status
- COMPLETED
- Phase
- PHASE2
A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Concomitant Intensity-modulated Radiotherapy Combined to Capecitabine, Mitomycin and Panitumumab in Patients With Stage II-IIIB Squamous-cell Carcinoma of the Anal Canal
- Status
- TERMINATED
- Phase
- PHASE2
Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE3